sstr — TargetMol Chemicals

Cat No.	Product Name	Synonyms	Targets
T76544	Cyclic SSTR agonist octreotide
	Cyclic SSTR agonist octreotide is a Octreotide , serving as the cyclic Somatostatin Receptor SSTR agonist [1] .
T9692	Paltusotine		Somatostatin
	Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients		Somatostatin
TP2207	Pasireotide Acetate		Somatostatin
	Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic		Somatostatin
T2584	Octreotide	SMS 201-995	Somatostatin
	Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin.		Somatostatin
T4119	Octreotide Acetate	SMS 201995,Longastatin,Sandostatin,SMS 201-995 (acetate)	Somatostatin
	Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone.		Somatostatin
T13022	SSTR5 antagonist 2		Others
	SSTR5 antagonist 2 is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5),with potential to treat type 2 diabetes mellitus (T2DM).		Others
T13005	SSTR5 antagonist 1		Others
	SSTR5 antagonist 1 is a selective, and orally available antagonist of somatostatin receptor subtype 5 (SSTR5)(IC50s of 9.6 and 57 nM for hSSTR5 and mSSTR5, respectively).		Others
T13022L	SSTR5 antagonist 2 TFA		Others
	SSTR5 antagonist 2 TFA is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5), with potential to treat type 2 diabetes mellitus (T2DM).		Others
TP2045	CH 275
	Potent somatostatin receptor 1 (sst1) agonist; displays selectivity for sst1 (IC50 values are 30.9 nM, 345 nM, > 1 μM, > 10 μM and > 10μM for human sst1, sst3, sst4, sst2 and sst5 respectively). Attenuates somatostatin r...
T61130	SSTR4 agonist 3
	SSTR4 agonist 3 is a potent compound that activates the SSTR4 receptor. The SSTR4 receptor is highly expressed in the hippocampus and neocortex, which are regions associated with memory, learning, and Alzheimer's disease...
T60911	SSTR4 agonist 4
	SSTR4 agonist 4 is a potent SSTR4 agonist that has the potential for the pain research. SSTR4 agonists are effective in rodent models of pain associated with acute and chronic associated anti-peripheral nociceptive and a...
T64119	SSTR5 antagonist 2 hydrochloride
	SSTR5 antagonist 2 hydrochloride is a potent, orally active, selective growth hormone inhibitory hormone (receptor) subtype 5 (SSTR5) antagonist that has shown potential for investigation in type 2 diabetes.
T60784	SSTR4 agonist 2
	SSTR4 agonist 2 is a potent somatostatin receptor subtype 4 (SSTR4) agonist that has the potential in SSTR4-related medical disorders research. SSTR4 pathway inhibits the processes of nociceptive and inflammatory [1].
T80238	NODAGA-LM3 TFA
	NODAGA-LM3 TFA, a SSTR2 antagonist, can be radiolabeled with ^68Ga for PET imaging applications, particularly in the visualization of SSTR-positive paragangliomas [1] [2].
T80237	NODAGA-LM3
	NODAGA-LM3, when labeled with ^68Ga, serves as a PET imaging agent. As an SSTR2 antagonist, ^68Ga-NODAGA-LM3 is utilized for the visualization of SSTR-positive paragangliomas [1] [2].
T78110	DOTA-LM3 TFA
	DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist with the molecular structure p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2. It is effectively used in tracing tumors in vivo through iso...
T80155	DOTA-LM3
	DOTA-LM3 is a somatostatin receptor (SSTR) antagonist, with LM3 denoting the peptide sequence p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2. It is utilized in the isotopic labeling of tumors for...
T76980	Tidutamab
	Tidutamab (XmAb-18087) is a bispecific antibody (bsAb) that is both humanized and optimized for affinity, targeting the SSTR2 and CD3 domains to bind to the somatostatin receptor 2 (SSTR2) and T cells, respectively. It f...